Classification
Product TypeIngredient
Product FormBulk ingredient (powder or liquid)
Industry PositionNutraceutical and personal-care ingredient
Market
In the United States, panthenol (including DL-panthenol and the biologically active D-form, dexpanthenol) is a functional ingredient used across downstream manufacturing, especially personal-care/cosmetics and certain health/wellness products positioned around provitamin B5. The U.S. market role is primarily downstream consumption and formulation, with commercial supply commonly moving through importers/distributors and U.S. manufacturers operating under the regulatory framework applicable to the intended use (e.g., dietary supplement vs cosmetic). For supplement-positioned products, FDA rules emphasize manufacturer responsibility for preventing adulteration/misbranding, following dietary supplement cGMP, and complying with labeling format requirements. For cosmetics, MoCRA expanded FDA oversight through facility registration and product listing expectations, shaping compliance and documentation workflows for ingredient-containing products.
Market RoleImport-dependent end-use market with significant domestic formulation/manufacturing
Domestic RoleDownstream manufacturing input for U.S. dietary supplement, cosmetic/personal care, and related formulation sectors
Specification
Primary VarietyDexpanthenol (D-panthenol)
Secondary Variety- DL-panthenol (racemic panthenol)
- Panthenol solutions (e.g., ~75%)
Compositional Metrics- Isomer/enantiomer form (D vs DL) is a core identity attribute because biological activity is associated with the D-form.
Supply Chain
Value Chain- Bulk ingredient production (often offshore) → bulk packaging → U.S. importer/distributor → U.S. GMP-controlled receiving/testing (as applicable) → formulation/manufacturing into finished supplements or cosmetic products → retail distribution
Freight IntensityLow
Transport ModeSea
Risks
Regulatory Compliance HighShipments and finished products tied to dietary supplement use can be delayed, detained, or refused if required FDA prior notice is missing (when applicable) or if documentation/testing is insufficient to support identity and component control under dietary supplement cGMP expectations.Use an intended-use decision tree (supplement vs cosmetic vs other), confirm prior notice applicability before shipment, and maintain a lot-specific compliance dossier (COA, identity/specification, traceability, and receiving test/verification records aligned with 21 CFR Part 111 where applicable).
Labor And Human Rights HighUFLPA enforcement can result in CBP detentions if panthenol or upstream chemical inputs are suspected to be linked in whole or in part to Xinjiang or an entity on the UFLPA Entity List, creating sudden supply interruptions for U.S. manufacturers.Map the upstream supply chain beyond the immediate supplier, obtain origin and input attestations, and prepare rebuttal documentation consistent with CBP UFLPA guidance if sourcing involves higher-risk jurisdictions.
Logistics MediumOcean freight delays and port congestion can disrupt replenishment timing for B2B manufacturing schedules even when freight cost sensitivity is moderate, especially for single-source qualified materials.Qualify at least one alternate supplier/grade where feasible, hold safety stock aligned to production lead times, and use dual-lane logistics planning (sea with contingency air for small lots).
Quality And Adulteration MediumMis-specification (including wrong isomer form) or inadequate impurity control can create nonconformance for the intended regulatory pathway (supplement vs cosmetic), triggering rework, recalls, or enforcement exposure.Specify isomer form explicitly in purchasing specs, require lot-level COA plus risk-based confirmatory testing, and enforce supplier change-notification and audit rights.
Sustainability- Environmental management expectations for upstream chemical manufacturing (wastewater, emissions, and solvent/energy management) can influence supplier qualification in U.S. buyer audits.
Labor & Social- U.S. import enforcement against forced labor under the Uyghur Forced Labor Prevention Act (UFLPA) can create detention risk if panthenol or upstream inputs are linked to Xinjiang or an entity on the UFLPA Entity List; supply chain mapping and documentation are critical.
Standards- Third-party dietary supplement/dietary ingredient standards (e.g., NSF/ANSI 173) may be requested by U.S. buyers depending on channel and risk posture.
- Food safety management system certification (e.g., FSSC 22000) may be relevant when the ingredient is handled within food/dietary ingredient facilities.
FAQ
What is the difference between panthenol and dexpanthenol, and why does it matter for supplements?Panthenol is commonly sold as a racemic mixture (DL-panthenol), while dexpanthenol is the dextrorotatory (D) form. PubChem notes that only the dextrorotatory form is biologically active and can be converted to pantothenic acid (vitamin B5), so buyers often specify the isomer form as part of identity and quality requirements.
If panthenol is used in a U.S. dietary supplement product, what U.S. compliance areas usually apply?For dietary supplement products, FDA requirements commonly center on dietary supplement cGMP (21 CFR Part 111) for manufacturing/packaging/holding operations and on correct 'Supplement Facts' labeling format rules (21 CFR 101.36). If an ingredient is considered a new dietary ingredient, FDA describes a notification process that may apply before marketing.
When importing panthenol into the United States for use in supplements, is FDA Prior Notice relevant?FDA guidance explains that prior notice applies to imported food shipments that are subject to the regulation, and the listed categories include dietary supplements and dietary ingredients. Whether a specific panthenol shipment is subject to prior notice depends on how it is classified and intended for use at import.